PRIMARY STUDY

An early economic analysis of medical cannabis for the treatment of chronic pain

Key Findings:  This study found that cannabis-based medicinal products (CBMPs) for chronic pain management in the UK are cost-effective, with potential for significant cost savings and reduced resource use due to their comparative effectiveness, and predicted even greater savings as prescribing costs decrease.